Drugs For Diabetes

Diabetes Medication Article

Types of Insulin Delivery Devices

All insulin delivery devices inject insulin through the skin and into the fatty tissue below.
Most people inject the insulin with a syringe that delivers insulin just under the skin. Others use insulin pens, jet injectors, or insulin pumps. Several new approaches for taking insulin are under development.

Insulin Pumps
Insulin pumps are small pumping devices worn outside of your body. They connect by flexible tubing to a catheter that is located under the skin of your abdomen. You program the pump to dispense the necessary amount of insulin. Usually, you set the pump to give a steady small dose of insulin, but you can give an additional amount in a short time if needed, such as after a meal. If adjusted properly, these pumps allow close control of your insulin levels without multiple injections. You should not use this type of pump during physical activities that may damage the pump or disrupt the pump's connection to the body. You still need to monitor your blood glucose levels regularly if you use this type of device.

Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat

Drugs For Diabetes News

Drugs for diabetes

Go to the new RSS page and renew your subscription.]]>

IMPORTANT: Bing News RSS feed has moved!

Advisers to the European drug regulator recommended approval of an experimental diabetes drug that was rejected by U.S. regulators earlier this year amid concerns about its safety. Shares of the drug's co-developers, Bristol-Myers Squibb Co. and ...

EU Body Backs Diabetes Drug U.S. Rejected

The latest data on this novel heart stent, which received approval from the U.S. Food and Drug Administration (FDA) last month with a first-of-its-kind indication for the treatment of coronary artery disease in patients with diabetes mellitus ...

Medtronic Resolute® Drug-Eluting Stent Delivers Durable Clinical Outcomes Through Two Years in Major Studies

EU body backs AstraZeneca, Bristol-Myers drug

FRANKFURT, Germany — AstraZeneca and Bristol-Myers Squibb's experimental diabetes treatment dapagliflozin won the backing of the European Union's pharmaceutical regulator, three months after the drug failed to gain approval in the United States.

Diabetes Drug Wins EU Backing (Frankfurt)

WINSTON-SALEM, N.C. (AP) -- Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients ...

Targacept slips on mixed results from drug studies

UPDATE: EU Body Backs AstraZeneca, Bristol's Diabetes Drug US Rejected

Reuters Market Eye - Sun Pharmaceutical Industries (SUN.NS) rose 2.4 percent after the U.S. Supreme Court allowed the Indian drug maker to sue a brand name rival in a bid to develop a generic diabetes drug for the U.S. market. Caraco ...

Sun Pharma up on U.S. court's diabetes ruling

According to a study published in , the combination of insulin and metformin may not benefit individuals with type 2 diabetes. Although the combination results in less weight gain, improved blood glucose control and less need for insulin, the ...

Insulin Usually Better Than Oral Drugs For Type 2 Diabetes

WASHINGTON — A consumer advocacy group is calling on government regulators to withdraw a diabetes drug from Novo Nordisk, saying the injectable medication raises the risk of thyroid cancer, pancreatitis and kidney failure. Public Citizen sent ...